Duopharma Q4 revenue rises

For its financial year ended Dec 31, 2021, Duopharma posted a net profit of RM65.68mil, up 12% from RM58.61mil in 2020, while revenue climbed to RM639.18mil against RM569.90mil a year ago.

KUALA LUMPUR: Duopharma Biotech Bhd’s net profit for its fourth quarter ended Dec 31, 2021 dropped to RM15.72mil from RM16.19mil in the previous corresponding period, while revenue rose to RM145.44mil compared with RM134.09mil a year earlier.

For its financial year ended Dec 31, 2021, Duopharma posted a net profit of RM65.68mil, up 12% from RM58.61mil in 2020, while revenue climbed to RM639.18mil against RM569.90mil a year ago.